Map Unavailable
Date/Time
Date(s) - 02/14/2025
9:00 am - 9:50 am
Category(ies)
Date: Friday, February 14, 2025
Time: 9:00 – 9:50 a.m., SCOB 228
Faculty Host: Issis Gutierrez, Employer Relations with Ira A. Fulton Schools of Engineering
BME Industry Panel Seminar Flyer
Abstract: Come to the BME Industry panel. This week, four representatives in industry will go over their career paths, share their experience in industry, discuss job opportunities at their organizations and their tips to for what they look for in prospective applicants.
Oliver Graudejus: Dr. Oliver Graudejus, PhD, is the founder of BioMedical Sustainable Electronic Devices (BMSEED). BMSEED’s core mission is to provide innovative solutions to electrically and mechanically interfaces with living tissue, both in vitro and in vivo, with the goal to improve people’s lives. Oliver Graudejus developed the core technology for the business while working at Princeton University from 2006 to 2009. He is the principal investigator on a several SBIR grants from NIH (total awarded: $6M) to commercialize the technology for in vitro research on neurotraumatic injuries and neurodegenerative diseases, Organ-on-Chip, and brain organoid applications, and to demonstrate the capabilities stretchable electrodes in brain and peripheral nerve implants, respectively. From 1999 to 2006, he worked in the semiconductor equipment industry for Novellus Systems (now part of Lam Research) in business development as a key account technologist. In this role, he worked closely with customers in the US, Asia, and Europe. He received a PhD in chemistry (1996) from the Justus-Liebig University in Giessen (Germany) for work on synthesis and characterization of transition metal fluorides in high oxidation state. He was awarded an Alexander von Humboldt Fellowship to work with Prof. Neil Bartlett at UC Berkeley on synthesis of fluorides in anhydrous hydrofluoric acid (1996-1999). He is the co-author of 31 peer-reviewed scientific publications and the co-inventor of one granted patent and two patent applications.
Kelvin Ning: Kelvin Ning is a serial medical entrepreneur with over 25 years of experience. Kelvin received his BS in Chemical Engineering at BYU. A serial entrepreneur with a hands-on problem-solving philosophy. A unique background in the industry for a medical device start-up including R&D, operations, clinical operations and quality. A chemical engineer with an emphasis in biomedical. Completed reimbursement training and an MBA in finance. Kelvin formed an incubator where he successfully spun out Nectero Medical, a drug / device combination company for small to mid-sized abdominal aortic aneurysms. Nectero closed their Series D financing in 2024 with $96MM. Kelvin designed Nectero’s drug and delivery catheter and has been working as their Senior Vice President of Technology since 2018. Kelvin has been married for 20 years and enjoys raising his 4 boys in Phoenix.
Anthony Silva: Anthony Silva is a Senior Development Engineer at Remedy Medical Manufacturing, where he collaborates with clients to bring innovative medical devices to market. With a strong foundation in engineering and cross-functional teamwork, Anthony’s expertise drives innovative solutions from concept to commercialization. Anthony holds a B.S.E. and M.S. in biomedical engineering from Arizona State University. During his time at ASU, he gained valuable experience working in Dr. Brent Vernon’s biomaterials lab, where he explored cutting-edge research in polymer science. His career began with the clinical engineering team at Banner Health, where he contributed to improving healthcare technologies, before transitioning to his current role with Remedy Medical Manufacturing. An Arizona native from Nogales, Anthony’s perspective is rooted in community and innovation. Currently, Anthony is instrumental in assisting Phoenix-area startups realize their visions. Over the course of his short career, he has directly contributed to the development and commercialization of six diverse medical devices – ranging from an FDA class II brain implant to a commercially available mouthguard. Currently, he supports more than 15 clients, guiding them through the intricate process of transforming ideas into market-ready medical products. Anthony’s primary focus lies in silicone manufacturing, additive manufacturing (3D printing), and regulatory compliance, particularly FDA pathway guidance. His technical expertise and practical approach ensure that startups and established companies alike can navigate the challenges of medical device development with confidence.
Kaprao Fuegner: Kaprao (Kap) Fuegner is a Senior Quality Engineer at Remedy Medical Manufacturing, where he leads quality assurance efforts to ensure compliance with FDA regulations and ISO standards. With expertise in quality systems, audits, and validation, Kap has been instrumental in fostering a culture of quality within the organization. His commitment in revising and streamlining company processes has led to the remarkable achievement of eliminating nonconformities identified by the FDA and notified bodies. Kap earned his B.S.E. in Biomedical Engineering from Arizona State University. During his time at ASU, he conducted research in DNA nanotechnology and computational chemistry, honing a meticulous, analytical approach to problem-solving. Kap’s introduction to quality engineering began at Zimmer Biomet, where his role ignited a passion for quality assurance and provided a strong foundation in regulatory compliance, process improvement, and cross-functional collaboration. It was during his time at Zimmer Biomet that Kap discovered his love for the impactful and detail-oriented nature of quality engineering. Throughout his career, Kap has played a critical role in the successful development and launch of multiple medical devices, including a pediatric brain implant. Currently, Kap works closely with cross- functional Development and Manufacturing teams to drive design/process validations, ensure manufacturing readiness, and uphold rigorous quality standards, enabling the seamless transition of innovative concepts into reliable, market-ready medical devices.